# Application Workflows: LAB-016

**Experiment**: LAB-016 (Information DNA Application Discovery)
**Date**: 2026-07-19
**Phase**: 4 - Prototype Workflows

---

## Overview

This document designs representative workflows for Information DNA applications. Each workflow is evaluated conceptually without implementation.

---

## Workflow Categories

1. **Human → AI → Human** - Human communicates with AI via DNA
2. **AI → AI** - Standardized inter-AI communication
3. **Experiment → Genome** - Research synthesis workflow
4. **Knowledge → DNA → Governance** - Organizational decision workflow
5. **Incident → DNA → Prevention** - Incident response workflow

---

## Workflow 1: Human → AI → Human

### Purpose
Structured knowledge exchange between humans via AI mediation.

### Workflow

```
┌─────────┐
│ Human A │ (Has knowledge)
└────┬────┘
     │ Observation / Experience
     ▼
┌─────────┐
│  AI     │ (Extracts DNA)
│ Agent   │
└────┬────┘
     │ Information DNA
     ▼
┌─────────┐
│ Genome  │ (Validates & Stores)
│ Update  │
└────┬────┘
     │ Information DNA
     ▼
┌─────────┐
│  AI     │ (Formats for recipient)
│ Agent   │
└────┬────┘
     │ Structured Knowledge
     ▼
┌─────────┐
│ Human B │ (Receives knowledge)
└─────────┘
```

### DNA Structure Used
- Canonical Agreement
- Supporting Observations
- Confidence
- Provenance

### Example: Knowledge Transfer

**Human A (Expert) Input**:
```
"I've found that this approach works better with large datasets."
```

**AI Extraction**:
```yaml
DNA:
  canonical: "Approach X performs better with large datasets"
  evidence:
    - "Empirical observation: 10% improvement on 100K+ records"
  confidence: MEDIUM
  provenance: Expert interview, 2026-07-19
```

**Human B (Learner) Output**:
```
Based on evidence from [Expert], Approach X shows 10% improvement on large datasets.
Confidence: MEDIUM (limited test cases)
```

### Evaluation

| Aspect | Assessment |
|--------|------------|
| Feasibility | HIGH |
| Value Added | HIGH - Structured evidence |
| Complexity | MEDIUM |
| Risk | LOW |

---

## Workflow 2: AI → AI

### Purpose
Standardized knowledge transfer between AI systems.

### Workflow

```
┌─────────┐
│  AI     │
│ System A│ (Generates DNA)
└────┬────┘
     │ Information DNA
     ▼
┌─────────┐
│ Inter-AI│ (Validation & Format)
│ Protocol│
└────┬────┘
     │ Standardized DNA
     ▼
┌─────────┐
│  AI     │
│ System B│ (Consumes DNA)
└─────────┘
```

### DNA Structure Used
- All 9 fields
- Evolution tracking
- Relationships

### Example: Model Comparison

**AI System A Output**:
```yaml
DNA:
  canonical: "Model A outperforms Model B on text classification"
  supporting_observations:
    - obs_1: "Accuracy: A=92%, B=89%"
    - obs_2: "Latency: A=100ms, B=150ms"
  confidence: HIGH
  relationships:
    - supersedes: MODEL-BENCHMARK-001
  provenance: Benchmark, 2026-07-19
```

**AI System B Input**:
```yaml
Processing:
  - Read canonical agreement
  - Check confidence level
  - Validate relationships
  - Update internal knowledge
```

### Evaluation

| Aspect | Assessment |
|--------|------------|
| Feasibility | MEDIUM |
| Value Added | HIGH - Standardization |
| Complexity | HIGH |
| Risk | MEDIUM - Interoperability |

---

## Workflow 3: Experiment → Genome

### Purpose
Research synthesis via systematic DNA generation.

### Workflow

```
┌────────────┐
│ Experiment │ (Research results)
│    Run     │
└─────┬──────┘
      │ Raw data
      ▼
┌────────────┐
│ Observation│ (Extract observations)
│ Extraction │
└─────┬──────┘
      │ Observations
      ▼
┌────────────┐
│  Evidence  │ (Link to evidence)
│  Linking   │
└─────┬──────┘
      │ Evidence-linked observations
      ▼
┌────────────┐
│   DNA      │ (Synthesize DNA)
│ Synthesis  │
└─────┬──────┘
      │ Information DNA
      ▼
┌────────────┐
│   Gene     │ (Validate & promote)
│ Validation │
└─────┬──────┘
      │ Validated Gene
      ▼
┌────────────┐
│   Gene     │ (Update Genome)
│  Registry  │
└────────────┘
```

### DNA Structure Used
- All 9 fields
- Confidence derivation
- Evolution tracking

### Example: Scientific Synthesis

**Input**:
```
Study results: Treatment A reduces symptom X by 30%
Study results: Treatment B reduces symptom X by 25%
Study results: Treatment C has no significant effect
```

**Output (Synthesized DNA)**:
```yaml
DNA:
  canonical: "Treatment A is most effective for symptom X"
  supporting_observations:
    - obs_1: "Treatment A: 30% reduction"
    - obs_2: "Treatment B: 25% reduction"
    - obs_3: "Treatment C: no significant effect"
  variations:
    - "Effect size varies by patient population"
  confidence: MEDIUM
  limitations:
    - "Limited to short-term studies"
  provenance:
    - LAB-XXX
```

### Evaluation

| Aspect | Assessment |
|--------|------------|
| Feasibility | HIGH |
| Value Added | HIGH - Systematic synthesis |
| Complexity | MEDIUM |
| Risk | LOW |

---

## Workflow 4: Knowledge → DNA → Governance

### Purpose
Evidence-based governance decision workflow.

### Workflow

```
┌────────────┐
│ Knowledge  │ (Domain knowledge)
│   Input    │
└─────┬──────┘
      │ Knowledge
      ▼
┌────────────┐
│  Evidence  │ (Link evidence)
│  Collection│
└─────┬──────┘
      │ Evidence chain
      ▼
┌────────────┐
│   DNA      │ (Synthesize position)
│ Synthesis  │
└─────┬──────┘
      │ Information DNA
      ▼
┌────────────┐
│ Governance │ (Review DNA)
│   Review   │
└─────┬──────┘
      │ Approved DNA
      ▼
┌────────────┐
│  Decision  │ (Document decision)
│  Record    │
└────────────┘
```

### DNA Structure Used
- Canonical Agreement
- Supporting Observations
- Confidence
- Known Limitations
- Provenance

### Example: Policy Decision

**Input**:
```
"We should adopt the new security protocol."
```

**DNA Synthesis**:
```yaml
DNA:
  canonical: "Security Protocol X should be adopted"
  supporting_observations:
    - obs_1: "Reduces attack surface by 40%"
    - obs_2: "Industry standard"
    - obs_3: "Compatible with existing systems"
  confidence: HIGH
  limitations:
    - "Training cost estimated at $50K"
    - "Implementation timeline: 6 months"
  contradictions:
    - "Initial cost higher than current"
  provenance:
    - Security assessment, 2026-07-19
```

**Governance Review Output**:
```
DECISION: APPROVED
Based on: HIGH confidence evidence
Conditions: Training budget approved
Reviewed by: Governance Body
Date: 2026-07-19
```

### Evaluation

| Aspect | Assessment |
|--------|------------|
| Feasibility | HIGH |
| Value Added | VERY HIGH - Transparency |
| Complexity | LOW |
| Risk | LOW |

---

## Workflow 5: Incident → DNA → Prevention

### Purpose
Systematic incident learning and prevention.

### Workflow

```
┌────────────┐
│  Incident  │ (Incident occurs)
│  Occurs    │
└─────┬──────┘
      │ Incident data
      ▼
┌────────────┐
│   DNA      │ (Document incident)
│ Synthesis  │
└─────┬──────┘
      │ Incident DNA
      ▼
┌────────────┐
│  Pattern   │ (Find patterns)
│ Detection  │
└─────┬──────┘
      │ Patterns
      ▼
┌────────────┐
│  DNA       │ (Generate prevention)
│ Evolution  │
└─────┬──────┘
      │ Prevention DNA
      ▼
┌────────────┐
│  Process   │ (Update processes)
│  Update    │
└────────────┘
```

### DNA Structure Used
- Canonical Agreement
- Supporting Observations
- Relationships (to previous incidents)
- Confidence
- Evolution tracking

### Example: Incident Documentation

**Incident Input**:
```
Database outage caused by unpatched vulnerability.
```

**Incident DNA**:
```yaml
DNA:
  canonical: "Unpatched vulnerability caused database outage"
  supporting_observations:
    - obs_1: "Vulnerability CVE-XXXX was unpatched"
    - obs_2: "Attack exploited vulnerability"
    - obs_3: "Database unavailable for 2 hours"
  confidence: HIGH
  relationships:
    - similar_to: INCIDENT-DNA-001
    - similar_to: INCIDENT-DNA-002
  limitations:
    - "Root cause analysis incomplete"
```

**Prevention DNA (Generated)**:
```yaml
DNA:
  canonical: "Patch management process prevents similar incidents"
  supporting_observations:
    - obs_1: "Automated patch deployment"
    - obs_2: "48-hour patch SLA"
  confidence: MEDIUM
  evolution:
    - derived_from: INCIDENT-DNA-XXX
```

### Evaluation

| Aspect | Assessment |
|--------|------------|
| Feasibility | HIGH |
| Value Added | HIGH - Systematic learning |
| Complexity | MEDIUM |
| Risk | LOW |

---

## Cross-Cutting Concerns

### Workflow Common Elements

| Element | Implementation |
|---------|---------------|
| DNA Validation | Schema conformance check |
| Confidence Calculation | Evidence-based formula |
| Evolution Tracking | Version control |
| Traceability | Link to source |

### Workflow Risks

| Risk | Mitigation |
|------|------------|
| DNA overload | Prioritization mechanisms |
| Quality degradation | Validation checkpoints |
| Adoption friction | Gradual rollout |
| Governance gaps | Clear authority levels |

---

## Conclusion

All 5 workflow types are conceptually feasible:

1. **Human → AI → Human**: HIGH feasibility, HIGH value
2. **AI → AI**: MEDIUM feasibility, HIGH value
3. **Experiment → Genome**: HIGH feasibility, HIGH value
4. **Knowledge → DNA → Governance**: HIGH feasibility, VERY HIGH value
5. **Incident → DNA → Prevention**: HIGH feasibility, HIGH value

The **Knowledge → DNA → Governance** workflow offers the highest immediate value with lowest risk.
